Factors influencing the antifolate activity of synthetic tea-derived catechins

Molecules

Volumn 18, Issue 7, 2013, Pages 8319-8341

  Sáez Ayala, Magalí ^a   Fernández Pérez, María Piedad ^a   Chazarra, Soledad ^a   McHedlishvili, Nani ^b   Tárraga Tomás, Alberto ^a   Rodríguez López, José Neptuno ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b AGRICULTURAL UNIVERSITY OF GEORGIA   (Georgia)

Author keywords

Albumin; Antifolates; Dihydrofolate reductase; Drug design; Tea catechins

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; DIHYDROFOLATE REDUCTASE; FLAVONOID; FOLIC ACID; FOLIC ACID ANTAGONIST; POLYPHENOL; SERUM ALBUMIN; TEA;

APOPTOSIS; CELL PROLIFERATION; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; HUMAN; METABOLISM; SYNTHESIS; TEA; TUMOR CELL LINE; ARTICLE; DRUG EFFECT;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DESIGN; FLAVONOIDS; FOLIC ACID; FOLIC ACID ANTAGONISTS; HUMANS; POLYPHENOLS; SERUM ALBUMIN; TEA; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 84880818071     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18078319     Document Type: Article

References (35)

1. Mukhtar, H.; Ahmad, N. Cancer chemoprevention: future holds in multiple agents. Toxicol. Appl. Pharmacol. 1999, 158, 207-210.
2. Yang, C.S.; Chung, J.Y.; Yang, G.Y.; Li, C.; Meng, X.; Lee, M.J. Mechanisms of inhibition of carcinogenesis by tea. Biofactors 2000, 13, 73-79.
3. Shankar, S.; Ganapathy, S.; Srivastava, R.K. Green tea polyphenols: biology and therapeutic implications in cancer. Front. Biosci. 2007, 12, 4881-4899.
4. Nam, S.; Smith, D.M.; Dou, Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 2001, 276, 13322-13330.
5. Fang, M.Z.; Wang, Y.; Ai, N.; Hou, Z.; Sun, Y.; Lu, H.; Welsh, W.; Yang, C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63, 7563-7570.
6. Li, C.; Allen, A.; Kwagh, J.; Doliba, N.M.; Qin, W.; Najafi, H.; Collins, H.W.; Matschinsky, F.M.; Stanley, C.A.; Smith, T.J. Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J. Biol. Chem. 2006, 281, 10214-10221.
7. Navarro-Peran, E.; Cabezas-Herrera, J.; Garcia-Canovas, F.; Durrant, M.C.; Thorneley, R.N.; Rodriguez-Lopez, J.N. The antifolate activity of tea catechins. Cancer Res. 2005, 65, 2059-2064.
8. Alemdaroglu, N.C.; Wolffram, S.; Boissel, J.P.; Closs, E.; Spahn-Langguth, H.; Langguth, P. Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells. Planta Med. 2007, 73, 27-32.
9. Navarro-Peran, E.; Cabezas-Herrera, J.; Campo, L.S.; Rodriguez-Lopez, J.N. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int. J. Biochem. Cell. Biol. 2007, 39, 2215-2225.
10. Navarro-Martinez, M.D.; Navarro-Peran, E.; Cabezas-Herrera, J.; Ruiz-Gomez, J.; Garcia-Canovas, F.; Rodriguez-Lopez, J.N. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 2005, 49, 2914-2920.
11. Navarro-Peran, E.; Cabezas-Herrera, J.; Hiner, A.N.; Sadunishvili, T.; Garcia-Canovas, F.; Rodriguez-Lopez, J.N. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies. Biochemistry 2005, 44, 7512-7525.
12. Spina, M.; Cuccioloni, M.; Mozzicafreddo, M.; Montecchia, F.; Pucciarelli, S.; Eleuteri, A.M.; Fioretti, E.; Angeletti, M. Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate. Proteins 2008, 72, 240-251.
13. Kao, T.T.; Wang, K.C.; Chang, W.N.; Lin, C.Y.; Chen, B.H.; Wu, H.L.; Shi, G.Y.; Tsai, J.N.; Fu, T.F. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases-inhibition by folic acid and polyphenols. Drug Metab. Dispos. 2008, 36, 508-516.
14. Hannewald, P.; Maunit, B.; Muller, J.F. Screening of DHFR-binding drugs by MALDI-TOFMS. Anal. Bioanal. Chem. 2008, 392, 1335-1344.
15. Hong, J.; Lu, H.; Meng, X.; Ryu, J.H.; Hara, Y.; Yang, C.S. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002, 62, 7241-7246.
16. Sanchez-del-Campo, L.; Oton, F.; Tarraga, A.; Cabezas-Herrera, J.; Chazarra, S.; Rodriguez-Lopez, J.N. Synthesis and biological activity of a 3, 4, 5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate. J. Med. Chem. 2008, 51, 2018-2026.
17. Babich, H.; Zuckerbraun, H.L.; Weinerman, S.M. In vitro cytotoxicity of (-)-catechin gallate, a minor polyphenol in green tea. Toxicol Lett 2007, 171, 171-180.
18. Saez-Ayala, M.; Sanchez-del-Campo, L.; Montenegro, M.F.; Chazarra, S.; Tarraga, A.; Cabezas-Herrera, J.; Rodriguez-Lopez, J.N. Comparison of a pair of synthetic tea-catechin-derived epimers: Synthesis, antifolate activity, and tyrosinase-mediated activation in melanoma. ChemMedChem 2011, 6, 440-449.
19. Tückmantel, W.; Kozikowski, A.P.; Romanczyk, L.J. Studies in Polyphenol Chemistry and Bioactivity. 1. Preparation of building blocks from (+)-Catechin. Procyanidin formation. synthesis of the cancer cell growth inhibitor, 3-O-Galloyl-(2R, 3R)-epicatechin-4â, 8-[3-O-galloyl-(2R, 3R)- epicatechin]. J. Am. Chem. Soc. 1999, 121, 12073-12081.
20. Park, K.D.; Lee, S.G.; Kim, S.U.; Kim, S.H.; Sun, W.S.; Cho, S.J.; Jeong, D.H. Anticancer activity of 3-O-acyl and alkyl-(-)-epicatechin derivatives. Bioorg. Med. Chem. Lett. 2004, 14, 5189-5192.
21. Hirasawa, M.; Takada, K. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. J. Antimicrob. Chemother. 2004, 53, 225-229.
22. Cocco, L.; Roth, B.; Temple, C., Jr.; Montgomery, J.A.; London, R.E.; Blakley, R.L. Protonated state of methotrexate, trimethoprim, and pyrimethamine bound to dihydrofolate reductase. Arch. Biochem. Biophys. 1983, 226, 567-577.
23. Vyas, S.; Manon, B.; Vir Singh, T.; Dev Sharma, P.; Sharma, M. Potential O-acyl-substituted (-)-Epicatechin gallate prodrugs as inhibitors of DMBA/TPA-induced squamous cell carcinoma of skin in Swiss albino mice. Chem. Biodivers. 2011, 8, 599-613.
24. Ishii, T.; Minoda, K.; Bae, M.J.; Mori, T.; Uekusa, Y.; Ichikawa, T.; Aihara, Y.; Furuta, T.; Wakimoto, T.; Kan, T.; Nakayama, T. Binding affinity of tea catechins for HSA: characterization by high-performance affinity chromatography with immobilized albumin column. Mol. Nutr. Food Res. 2010, 54, 816-822.
25. Pal, S.; Saha, C.; Hossain, M.; Dey, S.K.; Kumar, G.S. Influence of galloyl moiety in interaction of epicatechin with bovine serum albumin: A spectroscopic and thermodynamic characterization. PLoS One 2012, 7, e43321.
26. Boulton, D.W.; Walle, U.K.; Walle, T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J. Pharm. Pharmacol. 1998, 50, 243-249.
27. Kratz, F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Controlled Release 2008, 132, 171-183.
28. Wunder, A.; Muller-Ladner, U.; Stelzer, E.H.; Funk, J.; Neumann, E.; Stehle, G.; Pap, T.; Sinn, H.; Gay, S.; Fiehn, C. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. J. Immunol. 2003, 170, 4793-4801.
29. Gao, S.; Feng, N.; Yu, S.; Yu, D.; Wang, X. Vasodilator constituents from the roots of Lysidice rhodostega. Planta Med. 2004, 70, 1128-1134.
30. Chazarra, S.; Aznar-Cervantes, S.; Sanchez-del-Campo, L.; Cabezas-Herrera, J.; Xiaofeng, W.; Cenis, J.L.; Rodriguez-Lopez, J.N. Purification and kinetic properties of human recombinant dihydrofolate reductase produced in Bombyx mori chrysalides. Appl. Biochem. Biotechnol. 2010, 162, 1834-1846.
31. Smith, S.L.; Patrick, P.; Stone, D.; Phillips, A.W.; Burchall, J.J. Porcine liver dihydrofolate reductase. Purification, properties, and amino acid sequence. J. Biol. Chem. 1979, 254, 11475-11484.
32. Montenegro, M.F.; Saez-Ayala, M.; Pinero-Madrona, A.; Cabezas-Herrera, J.; Rodriguez-Lopez, J.N. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation. PLoS One 2012, 7, e52231.
33. Sáez-Ayala, M.; Montenegro, M.F.; Sánchez-del-Campo, L.; Fernández-Pérez, M.P.; Chazarra, S.; Freter, R.; Middleton, M.; Piñero-Madrona, A.; Cabezas-Herrera, J.; Goding, C.R.; Rodríguez-López , J.N. Directed phenotype-switching as an effective anti-melanoma strategy. Cancer Cell. 2013, 24, 105-119.
34. Sánchez-del-Campo, L.; Rodríguez-López, J.N. Targeting the methionine cycle for melanoma therapy with 3-O-(3, 4, 5-trimethoxybenzoyl)-(-)-epicatechin. Int. J. Cancer 2008, 123, 2446-2455.
35. Fujita, T. Hydrophobic bonding of sulfonamide drugs with serum albumin. J. Med. Chem. 1972, 15, 1049-1056. (FS-RM)